PROVISTA DIAGNOSTICS
Provista Diagnostics is a Delaware company, develops and commercializes breakthrough, easy-to-administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The Company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near-term development and commercialization efforts focus on women's cancers such as breast and ovarian cancer. Provista Diagnostic’s technologies are developed at our CLIA accredited, GLP compliant, 13,610 sq/ft laboratory facility based in Scottsdale, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.
PROVISTA DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2007-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.provistadx.com
Total Employee:
11+
Status:
Active
Contact:
(212)202-3170
Email Addresses:
[email protected]
Total Funding:
34.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.provistadx.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.65 K
- Host name: 104.21.90.115
- IP address: 104.21.90.115
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Provista Diagnostics"
Provista Diagnostics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (212)202-3170 Provista Diagnostics is a Delaware company, develops and commercializes breakthrough, easy-to-administer blood-based diagnostic tests for early oncology-related …See details»
Terms of Use - provistadx.com
Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary blood-based diagnostic, prognostic and …See details»
Provista Diagnostics, Inc - Phone, Email, Employees, CEO, VP, 2024
Provista Diagnostics, Inc (https://www.provistadx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Provista Diagnostics - LinkedIn
Provista Diagnostics | 843 followers on LinkedIn. Your Neighborhood Early Detection Center for COVID-19 and Women's Health | Provista Diagnostics, your neighborhood early detection …See details»
Breast Cancer Blood Test Now Accessible Under Health
Jul 7, 2016 Susan LaMacchia Provista Diagnostics [email protected] 212-202-3174 Contact ...See details»
Provista Diagnostics - Craft
Provista Diagnostics is a molecular diagnostics company focused on developing and commercializing blood-based proteomic diagnostic, prognostic, and monitoring tests.See details»
Provista Diagnostics Information - RocketReach
Provista Diagnostics, your neighborhood early detection center based in Alpharetta, GA, is simplifying health diagnostics. Provista is creating empowering diagnostics for Women's …See details»
Provista Diagnostics: Revenue, Worth, Valuation & Competitors 2024
About Provista Diagnostics. Provista Diagnostics is a Biotech related company based in New York City with an estimated revenue of $1.9M, and 12 employees. It has 10 competitors including …See details»
Provista Diagnostics - Overview, News & Similar companies
Provista Diagnostics contact info: Phone number: (470) 758-2777 Website: www.provistadx.com What does Provista Diagnostics do? Videssa Breast is the first blood test of its kind to detect …See details»
PDF - Provista Diagnostics, Inc. - studylib.net
NEWS RELEASE Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP) NEW YORK, NY – June 26, 2014 – Provista Diagnostics, Inc., a …See details»
Early Breast Cancer Detection Test Unaffected by Breast Density in ...
[email protected] 212-202-3174 Early Breast Cancer Detection Test Unaffected by Breast Density in Women 25 – 75 Provista Diagnostics to Present New Data at 15th Human …See details»
Provista Diagnostics Appoints Judith K. Wolf, M.D., as
Jul 28, 2016 Susan LaMacchia Provista Diagnostics [email protected] 212-202-3174 Contact ...See details»
5 24 16 Provista Diagnostics to Present at BIO Internationational ...
Additional information about Provista Diagnostics is available at ProvistaDx.com. Information about Provista Diagnostics’ clinical trials is available at ClinicalTrials.gov. About BIO The BIO …See details»
PROV-PR-016 06:14 Provista Diagnostics Laboratory Receives ...
[email protected] 212-202-3170 Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP) ... is a hallmark of how we are building our …See details»
New Study: Videssa® Breast Blood Test Can Effectively Rule Out …
NEW YORK, Oct. 25, 2017 /PRNewswire/ -- A new study published in PLOS ONE demonstrates that Videssa ® Breast, a multi-protein biomarker blood test for breast cancer by Provista …See details»
Provista Diagnostics - News
Provista Diagnostics to Participate in BTIG’s Inaugural Emergin Technologies in Healthcare Diagnostics Symposium Sep 29, 2014 Provista Diagnostics, Inc., a privately-held molecular …See details»
A Noninvasive Blood-based Combinatorial Proteomic Biomarker
Electronic address: [email protected]. PMID: 28624156 DOI: 10.1016/j.clbc.2017.05.004 Abstract Background: Despite significant advances in breast imaging, the ability to detect …See details»
A Noninvasive Blood-based Combinatorial Proteomic Biomarker …
E-mail contact: [email protected] 516-Clinical Breast Cancer November 2017 1526-8209/ª 2017 ProvistaDx. Published by Elsevier Inc. This is an open access article ... third-party …See details»
Breast density does not impact the ability of Videssa® Breast
* [email protected] Abstract Breast density is associated with reduced imaging resolution in the detection of breast can-cer. A biochemical approach that is not affected by density would …See details»
PROV-PR-042 07:16 Breast Cancer Blood Test Now Accessible …
[email protected] 212-202-3174 Breast Cancer Blood Test Now Accessible Under Health Benefits for Millions of Women in the U.S. Provista Diagnostics Announces 13 Signed …See details»